Aktis Oncology AKTS

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: Boston, Massachusetts
Fiscal year end: 12/31
Next earnings: 10/20, estimated

No member of Congress reported a trade in Aktis Oncology AKTS in the past 90 days. Insiders filed 0 purchases and 2 sales on the open market over the same period, a net sale of $258.6K.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: −$258.6K; Last 90 days · bought $0 · sold $258.6K
Next earnings: 10/20; Estimated from the last four quarters

26-week trading

Common questions

Did Aktis Oncology AKTS insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 0 purchases and 2 sales on the open market. Sales came to $258.6K.